Carmine Stolfi

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 47

Top Venues

International journal of molecular sciences

Pharmaceutics

Cancers

The Journal of pathology

Università degli Studi di Roma Tor Vergata Dipartimento di Medicina dei Sistemi

Universita degli Studi di Roma Tor Vergata (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Roma Tor Vergata Dipartimento di Medicina dei Sistemi

Italy

Principal research scientist

Education History

Universita degli Studi di Roma Tor Vergata

Italy

PHD

Publications

Carmine Stolfi
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023". International journal of molecular sciences 25 (6) (2024)
Carmine Stolfi
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023". International journal of molecular sciences 25 (6) (2024)
Carmine Stolfi
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023". International journal of molecular sciences 25 (6) (2024)
Carmine Stolfi
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023". International journal of molecular sciences 25 (6) (2024)
Carmine Stolfi
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023". International journal of molecular sciences 25 (6) (2024)
Davide Di Fusco, Antonio Di Grazia, Giulia Di Maggio, Maria Teresa Segreto, Andrea Iannucci, Claudia Maresca, Alessandro De Stefano, Giuseppe Sica, Carmine Stolfi, Giovanni Monteleone, Ivan Monteleone
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer. Cell death & disease 14 (4) (2023)
Anderson Luiz-Ferreira, Carmine Stolfi
Special Issue "Drug Treatments for Inflammatory Bowel Diseases". Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Carmine Stolfi, Teresa Pacifico, Anderson Luiz-Ferreira, Giovanni Monteleone, Federica Laudisi
Anthelmintic Drugs as Emerging Immune Modulators in Cancer. International journal of molecular sciences 24 (7) (2023)
Silvia Salvatori, Irene Marafini, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. International journal of molecular sciences 24 (3) (2023)
Federica Laudisi, Carmine Stolfi
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue "State-of-the-Art Molecular Oncology in Italy". International journal of molecular sciences 24 (10) (2023)
Davide Di Fusco, Maria Teresa Segreto, Giulia Di Maggio, Andrea Iannucci, Claudia Maresca, Antonio Di Grazia, Marco Colella, Carmine Stolfi, Giovanni Monteleone, Ivan Monteleone
Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA. Cancers 15 (20) (2023)
Anderson Luiz-Ferreira, Teresa Pacifico, Álefe Cardoso Cruz, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi
TRAIL-Sensitizing Effects of Flavonoids in Cancer. International journal of molecular sciences 24 (23) (2023)
Giovanni Monteleone, Carmine Stolfi
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut † . The Journal of pathology 259 (3) (2023)
Giovanni Monteleone, Carmine Stolfi
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut † . The Journal of pathology 259 (3) (2023)
Giovanni Monteleone, Carmine Stolfi
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut † . The Journal of pathology 259 (3) (2023)
Anderson Luiz-Ferreira, Carmine Stolfi
Special Issue "Drug Treatments for Inflammatory Bowel Diseases". Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Giovanni Monteleone, Eleonora Franzè, Claudia Maresca, Marco Colella, Teresa Pacifico, Carmine Stolfi
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance. Cancers 15 (3) (2023)
Anderson Luiz-Ferreira, Carmine Stolfi
Special Issue "Drug Treatments for Inflammatory Bowel Diseases". Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Silvia Salvatori, Irene Marafini, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. International journal of molecular sciences 24 (3) (2023)
Carmine Stolfi, Teresa Pacifico, Giovanni Monteleone, Federica Laudisi
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier. Biomedicines 11 (7) (2023)
Giovanni Monteleone, Eleonora Franzè, Claudia Maresca, Marco Colella, Teresa Pacifico, Carmine Stolfi
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance. Cancers 15 (3) (2023)
Giovanni Monteleone, Carmine Stolfi
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut † . The Journal of pathology 259 (3) (2023)
Silvia Salvatori, Irene Marafini, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. International journal of molecular sciences 24 (3) (2023)
Giovanni Monteleone, Carmine Stolfi
Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. Pharmaceutics 15 (1) (2022)
Giovanni Monteleone, Carmine Stolfi
Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. Pharmaceutics 15 (1) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Carmine Stolfi, Claudia Maresca, Giovanni Monteleone, Federica Laudisi
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines 10 (2) (2022)
Claudia Maresca, Giulia Di Maggio, Carmine Stolfi, Federica Laudisi, Marco Colella, Teresa Pacifico, Antonio Di Grazia, Davide Di Fusco, Daniele Congiu, Andrea Martina Guida, Giuseppe Sica, Ivan Monteleone, Giovanni Monteleone
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells. Cancers 14 (20) (2022)
Antonio Di Grazia, Davide Di Fusco, Eleonora Franzè, Marco Colella, Georgios Strimpakos, Silvia Salvatori, Vincenzo Formica, Federica Laudisi, Claudia Maresca, Alfredo Colantoni, Angela Ortenzi, Carmine Stolfi, Ivan Monteleone, Giovanni Monteleone
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial-Mesenchymal Transition and Correlates with Progression of the Disease. Cancers 14 (21) (2022)
Giovanni Monteleone, Carmine Stolfi
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut † . The Journal of pathology (2022)
Giovanni Monteleone, Carmine Stolfi
Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. Pharmaceutics 15 (1) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Valeria Unida, Giulia Vindigni, Sofia Raniolo, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells. Pharmaceutics 14 (12) (2022)
Giovanni Monteleone, Carmine Stolfi
Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials. Pharmaceutics 15 (1) (2022)
Edoardo Troncone, Irene Marafini, Carmine Stolfi, Giovanni Monteleone
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer. International journal of molecular sciences 22 (8) (2021)
Giulia Vindigni, Sofia Raniolo, Federico Iacovelli, Valeria Unida, Carmine Stolfi, Alessandro Desideri, Silvia Biocca
AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy. Pharmaceutics 13 (10) (2021)
Sofia Raniolo, Valeria Unida, Giulia Vindigni, Carmine Stolfi, Federico Iacovelli, Alessandro Desideri, Silvia Biocca
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures. Cell death & disease 12 (1) (2021)
Davide Di Fusco, Irene Marafini, Carmine Stolfi, Edoardo Troncone, Sara Onali, Elisabetta Lolli, Flavio Caprioli, Stefano Mazza, Cascella Raffaella, Laura Manzo, Paola Borgiani, Paolo Giuffrida, Antonio Di Sabatino, Ivan Monteleone, Giovanni Monteleone
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease. Biomedicines 8 (8) (2020)
Antonio Di Grazia, Federica Laudisi, Davide Di Fusco, Eleonora Franzè, Angela Ortenzi, Ivan Monteleone, Giovanni Monteleone, Carmine Stolfi
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells. Cancers 12 (5) (2020)
Irene Marafini, Giovanni Monteleone, Carmine Stolfi
Association Between Celiac Disease and Cancer. International journal of molecular sciences 21 (11) (2020)
Federica Laudisi, Martin Marônek, Antonio Di Grazia, Giovanni Monteleone, Carmine Stolfi
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System. International journal of molecular sciences 21 (14) (2020)
Martin Marônek, René Link, Giovanni Monteleone, Roman Gardlík, Carmine Stolfi
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? International journal of molecular sciences 21 (21) (2020)
Eleonora Franzè, Carmine Stolfi, Edoardo Troncone, Patrizio Scarozza, Giovanni Monteleone
Role of Interleukin-34 in Cancer. Cancers 12 (1) (2020)
Carmine Stolfi, Edoardo Troncone, Irene Marafini, Giovanni Monteleone
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer. Biomolecules 11 (1) (2020)
Federica Laudisi, Fabio Cherubini, Antonio Di Grazia, Vincenzo Dinallo, Davide Di Fusco, Eleonora Franzè, Angela Ortenzi, Illari Salvatori, Silvia Scaricamazza, Ivan Monteleone, Naoya Sakamoto, Giovanni Monteleone, Carmine Stolfi
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells. Molecular oncology 13 (10) (2019)
Federica Laudisi, Fabio Cherubini, Giovanni Monteleone, Carmine Stolfi
STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment. International journal of molecular sciences 19 (6) (2018)

Carmine Stolfi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carmine Stolfi